U.S. FDA Grants Paige Breakthrough Device Designation for AI Application that Detects Cancer Across Different Anatomic Sites
Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types.
Solace Raises $60M Series B | To Establish Healthcare Advocacy as New Standard of Care
This raise reflects accelerating market conviction that healthcare advocacy is a critical standard of care that drives better outcomes, lowers costs, and enhances patient experiences notes Solace.
Experienced Medtech Executive Raymond W Cohen Appointed Chairman of Nalu Medical’s Board of Directors
Raymond W Cohen is an accredited public company director with more than 40 years of experience in the life sciences industry.
Dr. Vivien Bonazzi Named Chief Data Officer at Inari
Prior to joining Inari, Dr. Vivien Bonazzi served as chief biomedical data scientist and managing director at Deloitte Consulting LLP.
Pillar Biosciences Receives CMS Coverage for FDA Approved oncoReveal® CDx Pan-Cancer Solid tumor IVD Kit

oncoReveal® CDx is a NGS based IVD kit that uses Pillar’s proprietary SLIMamp (Stem-Loop Inhibition-Mediated amplification) technology for detection of single nucleotide variants (SNVs), insertions and deletions in 22 genes using DNA isolated from formalin-fixed paraffin-embedded (FFPE) tumor tissue specimens.
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
Through this collaboration, Onsite Women’sHealth will offer MammoScreen across its 150+ locations to elevate patient care, while empowering radiologists with AI-driven insights to support earlier and more accurate cancer detection.
Dräger Reports US availability of next- generation Polaris® OR lights
Innovations in surgical light technology can help ORs advance surgical precision, simplify workflow, and increase patient safety notes Dräger.
SimX and Elevate Healthcare Unite to Launch Next-Gen Healthcare Simulation Solutions
SimX, the leader in virtual reality (VR) healthcare training, and Elevate Healthcare, formerly CAE Healthcare, a global leader in simulation-based education, are proud to announce a strategic collaboration aimed at transforming the landscape of medical training and education. This collaboration will bring together SimX’s cutting-edge VR simulation platform and Elevate’s proven expertise in physical simulation […]
InfuSystem Announces CEO Transition | Carrie Lachance to Become CEO Effective May 19, 2025
“Carrie Lachance has been at the center of InfuSystem’s succession plan for the past several years, and she is the ideal person to succeed Rich DiIorio having spent the last decade plus working her way up through ever greater positions of responsibility within the Company,” said Scott Shuda, Chairman of the board of InfuSystem.
restor3d Receives FDA Clearance for iTotal IdentityTM CR 3DP Porous Fully Personalized Total Knee Replacement System
This milestone marks a significant achievement in expanding restor3d’s knee replacement technology since the acquisition of Conformis, introducing the first cementless offering to the patient-specific implant portfolio. The company plans a limited market release in Q3 of 2025.
ITM Appoints Dr. Celine Wilke Chief Medical Officer

“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in progressing our pipeline and delivering new treatment options for patients,” said Dr. Andrew Cavey, Chief Executive Officer of ITM.
Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.